
    
      The study is a prospective randomized controlled trial. Patients who will use NOACs are
      prospectively divided into routine group and pharmacist intervention group.

      For the intervention group, pharmacists regularly provide telephone and outpatient follow-up
      combined with patient medication education, establishing database system, telephone reminder,
      etc. At the 12-week follow-up, behavioral patterns of compliance, self-anxiety, depression
      status and satisfaction with the pharmacist service will be evaluated in both groups.
      Pharmacodynamic substitution indicators and endpoints will be collected as well.

      Clinical data is designed to be collected from 400 patients, 200 patients each group. Data
      will be recorded by Epidata dual-track, analyzed by SPSS19.0 software. P<0.05 is considered
      significant.
    
  